Jim Cramer found out that back to school season and a different sort of seasoning have been big boosts for CEOs.» Read More
Kevin Sayer, Dexcom CEO, joins Mad Money host Jim Cramer to discuss the innovative medical devices and technology the company produces.
Jim Cramer provides his opinion on various caller favorite stocks, including this liquified gas carrier play.
“Mad money” host Jim Cramer makes a call on China’s currency devaluation and which U.S. stocks can still win.
Jim Cramer speaks to the CEO of Cisco Systems on its strong quarter and the impact of China and cybersecurity on its future.
Jim Cramer discusses the headwinds faced by Macy's this quarter and questions whether investors should even buy bricks-and-mortar stocks anymore.
Jim Cramer saw three key bullish indicators that made him believe that this rally could be here to stay.
Jim Cramer gives his take at rapid speed for caller favorite stocks, including this terrific long-term stock.
Jim Cramer says the market has been selling off, and it’s made some stocks too cheap to ignore.
Jim Cramer provides his take on Google's new Alphabet. It's not just a bunch of letters.
Jim Cramer goes off the charts to look at the crude chaos. Could it be the time to build a portfolio for black crude again?
Jim Cramer saw some disturbing signals coming from China that could send the U.S. back to the Great Depression.
Jim Cramer dishes his opinion on caller favorite stocks, including this one that has become too hard for him.
“Mad Money” host Jim Cramer on what Google’s restructuring means for your portfolio. Easy as ABC?
Jim Cramer goes picking among the market rubble last week to find the beaten stocks ready to fly higher.
Jim Cramer warned investors not to get too excited, as the rally will reverse this week. Here's the best way to play it.
Jim Cramer says the market rally on Monday all boiled down to 10 reasons. However, he wants investors to remain skeptical.
Jim Cramer gives his opinion to caller favorite stocks, including this pipeline stock that he considers the best.
Dr. J. Joseph Kim, Inovio Pharmaceuticals CEO, joins Mad Money host Jim Cramer to discuss INO's compelling proprietary immunotherapy platform, cutting edge vaccine technology, and product pipeline moving forward.
In Jim Cramer's Executive Cut, the "Mad Money" host asks this CEO how he can stock his stock from falling any further.
“Mad Money” host Jim Cramer’s eyeing one statistic that could yay or nay a rate hike next month.
Grab the latest CNBC gear from the NBCUniversal Store!
You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.
Find out if the source of the surge continues next week, with Mad Money host Jim Cramer.
Before you hit the panic button, Cramer has something you must hear.
Find out his favorite between ABEV, STZ and TAP.